Your gateway to entrepreneurial success
News and analysis on UK and European Biotech VCs specialising in funding early-stage biotechnology companies that focus on developing innovative medical treatments, diagnostics, and technologies.
Venture Capital Funding
London-based biotech developing drugs to cure Alzheimer’s, a disease which affects 55m people a year and costs the economy tens of billions
Venture Capital Funding
Venture capital channels over £2m a day into biotech, accounting for two thirds of all biotech funding
Technology
Biotech business population flourishes since 2016 as annual investment reaches £2.2bn in 2018
News
Weed management business Weedingtech has added to the funding it received in the summer of 2013 by bagging a further £750,000.
News
The Seed Enterprise Investment Scheme (SEIS) has allowed biotechnology business Oxford Genetics to net £150,000 of new funding.
News
Early stage investment firms EV and Catapult Venture Managers have backed Liverpool-based molecular diagnostics company Biofortuna.
News
Sir Christopher Evans may have raised £100 million this year, but he is still worried about the lack of investment in the UK's biotech industry. He spoke to Mark Dunne
News
Pivotal Laboratories, a Yorkshire-based business that conducts clinical trials for pharmaceutical and biotech firms, has completed a multi-million-pound management buyout with the aid of Northern Venture Managers (NVM).